18F-labeled FECNT: A selective radioligand for PET imaging of brain dopamine transporters

Nuclear Medicine and Biology

Volumn 27, Issue 1, 2000, Pages 1-12

  Goodman, Mark M ^a   Kilts, Clinton D ^b   Keil, Robert ^a   Shi, Bing ^a   Martarello, Laurent ^a   Xing, Dongxia ^a   Votaw, John ^a   Ely, Timothy D ^b   Lambert, Philip ^b   Owens, Michael J ^b   Camp, Vernon M ^a   Malveaux, Eugene ^a   Hoffman, John M ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

Cocaine; Dopamine transporter; Fluorine 18 FECNT; Fluorotropane

Indexed keywords

3BETA (4 FLUOROPHENYL) 2BETA TROPANECARBOXYLIC ACID METHYL ESTER; CITALOPRAM; COCAINE; DESIPRAMINE; DOPAMINE TRANSPORTER; DRUG METABOLITE; FLUORINE 18; FLUVOXAMINE; NISOXETINE; NORTROPANE DERIVATIVE; RADIOLIGAND; VANOXERINE; 2 CARBOMETHOXY 3 (4 CHLOROPHENYL) 8 (2 FLUOROETHYL)NORTROPANE; 2-CARBOMETHOXY-3-(4-CHLOROPHENYL)-8-(2-FLUOROETHYL)NORTROPANE; CARRIER PROTEIN; DIAGNOSTIC AGENT; FLUORINE; LIGAND; MEMBRANE PROTEIN; NERVE PROTEIN; SLC6A3 PROTEIN, HUMAN; SLC6A3 PROTEIN, MOUSE; SLC6A3 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING SITE; BRAIN; BRAIN REGION; CAUDATE NUCLEUS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; EMBRYO; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY CELL; MALE; NONHUMAN; PUTAMEN; RAT; RHESUS MONKEY; TISSUE DISTRIBUTION; ANIMAL; BIOTRANSFORMATION; DOG; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MACACA; METABOLISM; MOUSE; SCINTISCANNING; SPRAGUE DAWLEY RAT; SYNTHESIS;

ANIMALS; AUTORADIOGRAPHY; BIOTRANSFORMATION; BRAIN; CARRIER PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOGS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FLUORINE RADIOISOTOPES; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; LIGANDS; MACACA MULATTA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; NERVE TISSUE PROTEINS; NORTROPANES; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033625020     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00080-3     Document Type: Article

References (28)

1. Aquilonius S.M., Bergstrom K., Eckernas S.A., Hartvig P., Leendeers K.L., Lundquist H., Antoni G., Gee A., Rimland A., Uhlin J., Langstrom B. In vivo evaluation of striatal dopamine reuptake sites using 11C-nomifensine and positron emission tomography. Acta. Neurol. Scand. 76:1987;283-287.
2. 123I]β-CIT) in non-human primates Pharmacokinetics, biodistribution and SPECT brain imaging co-registered with MRI . Nucl. Med. Biol. 20:1993;597-606.
3. Bernheimer H., Birkmayer W., Hornykiewcz O. Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations . J. Neurol. Sci. 20:1973;415-455.
4. Billings J., Kung M.P., Chumpradit S., Mozley D., Alavi A., Kung H.F. Characterization of radio-iodinated TISCH A high affinity and selective ligand for mapping CNS dopamine D-1 receptor . J. Neurochem. 58:1991;227-236.
5. 18F-fluorination of 1,N-disubstituted alkanes as fluoroalkylation agents. J. Labelled Compd. Radiopharm. 24:1987;1029-1042.
6. Carroll F.I., Lewin A.H., Boja J.W., Kuhar M.J. Cocaine receptor Biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter . J. Med. Chem. 35:1992;969-981.
7. Chaly T., Dhawan V., Kazumata K., Antonini A., Margoulef C., Dahl R., Belakhef A., Margoulef D., Yee A., Wang S., Tamagnan G., Neumeyer J.L., Eidelberg D. Radiosynthesis of [18F]N-3-fluoropropyl-2-β-carbomethoxy-3-β-(4-iodophenyl) nortropane and the first human study with positron emission tomography. Nucl. Med. Biol. 23:1996;999-1004.
8. 11C-WIN 35,428) . J. Labelled Compd. Radiopharm. 33:1993;147-152.
9. Ding Y., Fowler J., Volkow N., Logan J., Gatley S., Sugano Y. Carbon-11-d-threo-methylphenidate binding to dopamine transporter in baboon brain. J. Nucl. Med. 36:1995;2298-2305.
10. Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., Macgregor R.R., Hitzemann R., Logan J., Bendriem B., Gatley S.J. Mapping cocaine binding sites in human and baboon brain in vivo. Synapse. 4:1989;371-377.
11. 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease. Ann. Neurol. 34:1993;423-431.
12. Giros B., Jaber M., Jones S.R., Wightman R.M., Caron M.G. Hyper-locomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature. 379:1996;606-612.
13. Goodman M. M. (1991) Automated synthesis of radiotracers for positron emission tomography applications. In: Clinical Positron Emission Tomography (PET) (Edited by Hubner K. F., Buonocore E., Collmann J. and Kabalka G. W.), pp. 110-122. Mosby-Year Book, Inc., St. Louis, MO.
14. 18F]-N-3-fluoropropyl-2β-carbomethoxy-3β-4-chlorophenyl) tropane A high affinity neuroligand to map dopamine uptake sites by PET . J. Labelled Compd. Radiopharm. 34:1994;488-490.
15. Goodman M.M., Keil R., Shoup T.M., Eshima D., Eshima L., Kilts C., Votaw J., Camp V.M., Votaw D., Smith E., Kung M.P., Malveaux E., Watts R., Huerkamp M., Garcia E., Hoffman J.M. Fluorine-18 labeled 2β-carbomethoxy-3β-(4-chlorophenyl)-8-(3-fluoropropyl)nortropane (FPCT) A PET radiotracer for imaging dopamine transporters . J. Nucl. Med. 38:1997;119-126.
16. 11C]β-CIT-FE, a radioligand for quantitation of the dopamine transporter in the living brain using positron emission tomography. Synapse. 22:1996;386-390.
17. Kaufman M.J., Madras B.K. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's diseased striatum. Synapse. 49:1991;43-49.
18. Kilbourn R., Haka M.S. Synthesis of [18F]GBR 13119 A pre-synaptic dopamine uptake antagonist . Appl. Radiat. Isot. 39:1988;279-282.
19. Kilbourn M.R. In vivo binding of [18F]GBR 13119 to the brain dopamine uptake system. Life Sci. 42:1988;1347-1353.
20. Kilbourn M.R., Carey J.E., Koeppe R.A., Haka M.S., Hutchins G.A., Sherman P.S., Kuhl D.E. Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivo. Nucl. Med. Biol. 16:1989;569-576.
21. Logan J., Fowler J.S., Volkow N.D., Wolf A.P., Dewey S.L., Schlyer D.J., Macgregor R.R., Hitzemann R., Bendriem B., Gatley S.J., Christman D.R. Graphical analysis of reversible radioligand binding from time-activity measurements applied to measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 5:1990;740-747.
22. 11C]β-CIT-FP, a potential radioligand for quantitation of the dopamine transporter Preparation, autoradiography, metabolite studies, and positron emission tomography examinations . Nucl. Med. Biol. 22:1995;905-913.
23. 18F]β-CIT-FP, for quantitation of the dopamine transporter. Nucl. Med. Biol. 24:1997;621-627.
24. Meltzer P.C., Liang A.Y., Brownell A.L., Elmaleh D.R., Madras B.K. Substituted 3-phenyltropane analogs of cocaine Synthesis, inhibition of binding at cocaine recognition sites, and positron emission tomography imaging . J. Med. Chem. 36:1993;855-862.
25. 11C]β-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations. Nucl. Med. Biol. 20:1993;249-255.
26. Niznik H.B., Fogel E.F., Fassos E.F., Seeman P. The dopamine transporter is absent in Parkinson's putamen and reduced in the caudate nucleus. J. Neurochem. 56:1991;192-198.
27. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., Vitkun S., Logan J., Gatley S.J., Pappas N., Hitzemann R., Shea C.E. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature. 386:1997;827-830.
28. Wilson A.A., DaSilva J.N., Houle S. In vivo evaluation of [11C]- and [18F]-labelled cocaine analogues as potential dopamine transporter ligands for positron emission tomography. Nucl. Med. Biol. 23:1996;141-146.